VPg linkage to the 5'-ends of picornavirus RNAs requires production of VPg-pUpU. VPgpUpU is templated by an RNA stem-loop (the cre or oriI) found at different locations in picornavirus genomes. At least one adaptive mutation is required for HRV-14 to use PV-3 or PV-1 oriI efficiently. One mutation changes Leu-94 of 3C to Pro; the other changes Asp-406 of 3Dpol to Asn. By using an in vitro VPg uridylylation system for HRV-14 that recapitulates biological phenotypes, we show that the 3C adaptive mutation functions at the level of 3C(D), and the 3D adaptive mutation functions at the level of 3Dpol. Pro-94 3C(D) has an expanded specificity and enhanced stability relative to wild-type 3C(D) that leads to production of more processive uridylylation complexes. PV-1-HRV-14 oriI chimeras reveal sequence specificity in 3C(D) recognition of oriI that resides in the upper stem. Asn-406 3Dpol is as active as wildtype 3Dpol in RNA-primed reactions but exhibits greater VPg uridylylation activity due to more efficient recruitment to and retention in the VPg uridylylation complex. Asn-406 3Dpol from PV-1 exhibits identical behavior. These studies suggest a two-step binding mechanism in the assembly of the 3C(D)-oriI complex that leads to unwinding of at least the upper stem of oriI and provide additional support for a direct interaction between the back of the thumb of 3Dpol and 3C that is required for 3Dpol recruitment to and retention in the uridylylation complex.
INTRODUCTION 1 8 and 10-11 ( Table 1) encoding point mutation D406N. These two fragments were then used as templates for the amplification of a new fragment using oligonucleotides 7 and 8 ( Table 1) . The PCR products of 3D WT and 3D D406N were cloned into pET26Ub using SacII and XhoI sites. Table 1) were used to amplify 3C WT. For 3C L94P, first two PCR fragments were amplified using the oligonucleotides 1-2 and 3-4 ( Table 1 ) encoding point mutation L94P. These two fragments were then used as templates for the amplification of a new fragment using oligonucleotides 1 and 2 ( Table 1 ). The PCR products of 3C WT and 3C L94P were cloned into pET26Ub-Chis plasmid using SacII and BamHI sites. The pET26Ub-Chis is designed to produce a C-terminal GSSG-6His tag for any protein-coding sequence cloned in by using the 3' BamHI1 site.
Construction of pET26Ub HRV-14 3CD and 3CD derivatives. The pET26Ub 3CD Chis was
made the same way as described for the pET26Ub 3C Chis. Three 3CD mutants 3C*D (3C-L94P-D), 3CD* (3CD-D406N), and 3C*D* (3C-L94P-D-D406N) were made by PCR mutagenesis as described above. Oligonucleotides 1, 3-4 and 8 were used for 3C*D, oligonucleotides 1 and 7-9 were used for 3CD*, and oligonucleotides 1, 3-4 and 7-9 were used for 3C*D* PCR amplifications. All plasmids contain mutation of cysteine 146 to a glycine to inactivate protease activity.
Construction of pET26Ub PV 3D D406N. pET26Ub PV 3D-D406N was constructed as described previously for 3D-WT (8) . Oligonucleotides 14-17 (Table 1) were used for the PCR amplifications. The PCR products were cloned into pET26Ub-3D-WT using KpnI and EcoRI sites. Expression and purification of HRV-14 3D polymerase. E. coli, Rosetta pUbpS was transformed with pET26Ub HRV-14 3D WT or 3D D406N for protein expression. The strain of Rosetta pUbpS carries the pUbpS plasmid, which constitutively expresses a yeast ubiquitin protease that processes the ubiquitin fusion protein to produce the authentic N terminus. Protein expression, precipitation of nucleic acid with polyethyleneimine and ammonium sulfate precipitation were performed as previously described (22). The ammonium sulfate pellet was resuspeded in buffer A (50 mM Tris, pH 8.0, 0.1% Nonidet P-40, 20% glycerol, 10 mMmercaptoethanol) containing 150 mM NaCl, and dialyzed against 1000 ml of dialysis buffer (buffer A with 150 mM NaCl) at 4ºC overnight. After dialysis, the protein was adjusted to 50 mM NaCl and loaded at the speed of 1 ml/min onto a phosphocellulose (P-11) column equilibrated with buffer A containing 50 mM NaCl. Proteins were eluted with a gradient from 50 to 350 mM NaCl in buffer A. The eluted pooled fractions were loaded to a Q-Sepharose column as described for P-11 column. The eluted fractions were adjusted with buffer A to 50 mM NaCl, and loaded to 0.5 ml Q column, which was equilibrated with buffer A containing 50 mM NaCl.
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After loading, the column was washed with buffer B (50 mM HEPES, pH 7.5, 0.1% Nonidet P-40, 20% glycerol, 10 mM -mercaptoethanol) containing 50 mM NaCl. Proteins were eluted with buffer B containing 500 mM NaCl, and dialyzed against 1000 ml of buffer B containing 50 mM NaCl at 4ºC overnight. The protein concentration was determined at 280 nm in 6 M guanidine HCl, pH 6.5 using the extinction coefficients 0.0585 µM -1 .cm -1 . expression, lysis, PEI and ammonium sulfate precipitation were performed as previously described (22), except 60% ammonium sulfate precipitation was employed. The ammonium sulfate pellet was resuspeded in buffer A (50 mM Tris, pH 8.0, 0.1% Nonidet P-40, 20% glycerol, 10 mM -mercaptoethanol) containing 500 mM NaCl, and dialyzed against 1000 ml of dialysis buffer (buffer A with 500 mM NaCl) at 4ºC overnight. After dialysis, the protein was adjusted to 500 mM NaCl and loaded onto a Ni-NTA-agarose column at the flow rate of 1ml/min. The column was washed with 6x column volumes of buffer A containing 500 mM NaCl and 50 mM imidazole. Proteins were eluted with 2 M NaCl in buffer A containing 500 mM imidazole. The eluted pooled fractions were adjusted with buffer A to 50 mM NaCl and were purified using a phosphocellulose (P-11) column as described for HRV-14 3D purification. The protein concentration was determined at 280 nm in 6 M guanidine HCl, pH 6.5 using the extinction coefficients 0.0051 µM -1 .cm -1 .
Expression and purification of HRV-14 3CD WT and 3CD derivatives. The BL21(DE3)pCG1 strain of E. coli was transformed with pET26Ub HRV 14-3CD 6His for protein expression. The protein expression, lysis, PEI and ammonium sulfate precipitation were performed as previously described (22). The ammonium sulfate pellet was resuspeded in lysis buffer (100 mM potassium phosphate, pH 8.0, 0.1% Nonidet P-40, 20% glycerol, 10 mMmercaptoethanol, 500 mM NaCl, 2.8 µg/ml Pep A, 2.0 µg/ml leupeptin, 2 mM PMSF). The protein was loaded onto a Ni-NTA-agarose column at the flow rate of 1 ml/min. The column was washed with buffer B (50 mM HEPES, pH 7.5, 0.1% Nonidet P-40, 20% glycerol, 10 mM -mercaptoethanol) containing 500 mM NaCl and 20 mM imidazole. Proteins were eluted with 500 mM NaCl in buffer B containing 500 mM imidazole. The eluted pooled fractions were dialyzed against 1000 ml of dialysis buffer (buffer B with 150 mM NaCl) at 4ºC overnight. After 9
on July 8, 2017 by guest http://jvi.asm.org/ Downloaded from dialysis, the protein was adjusted to 50 mM NaCl and loaded at the speed of 1ml/min onto a phosphocellulose (P-11) column equilibrated with buffer B containing 50 mM NaCl, and eluted with buffer B containing 500 mM NaCl. The eluted pooled fractions were dialyzed against buffer B containing 150 mM NaCl at 4ºC overnight. The protein concentration was determined at 280 nm in 6 M guanidine HCl, pH 6.5 using the extinction coefficients 0.0636 µM -1 .cm -1 .
Subgenomic replicon assays. Subgenomic HRV-14 replicons were constructed as described previously (32). RNAs transcribed in vitro from these constructs were transfected into HeLa cells, which were seeded into 6-well plates, and cultured in DMEM with 10% FBS at 34°C. Cell lysates were harvested by the addition of 125 ml of passive lysis buffer (Promega) to each well, and stored at -70°C until assayed for enzymatic activity. Luciferase activity was quantified using the Luciferase Assay System as described by the supplier (Promega), and the results were determined using a TD-20/20 luminometer (Turner designs).
VPg uridylylation assays. The reaction mixture contained 1 µM 3C, or 3CD, 1 µM HRV-14 97-nt oriI or PV 61-nt oriI and 10 µM VPg in reaction buffer (50 mM HEPEs, pH 7.5, 5 mM magnesium acetate, 10% glycerol, 10 mM -mercaptoethanol, 0.04 µM [ -32 P] UTP (6,000
Ci/mmol), and 10 µM unlabeled UTP. Reaction mixture was preheated at 30ºC for 5 min.
Reactions were initiated with 3D (10 µM for HRV-14 or 1 µM for PV). All enzymes were diluted immediately prior to use in enzyme dilution buffer (50 mM HEPES, pH 7.5, 10 mMmercaptoethanol, and 20% glycerol). After incubation at 30ºC for 30 min, the reaction was then stopped by the addition of an equal volume (5 µl) of gel loading buffer (100 mM EDTA in 75% formamide, 0.025% bromophenol blue and 0.025% xylene cyanol). The quenched samples (5 µl) were analyzed on Tris-Tricine SDS-polyacrylamide gel electrophoresis. The incorporation of [ - The concentration of VPg extended was calculated using values for the counts associated with the indicated components in the equation:
The processivity of the reaction is defined as follows: (w/v) dibasic sodium phosphate. Bound radioactivity was quantified by liquid scintillation counting.
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A C C E P T E D mutations. There are differences in the sequence of the lower stem of PV-1 oriI relative to PV-3 oriI ( Fig. 2A) . Because HRV-14 oriI could be used by PV-1, it was important to show that the inability of PV-3 oriI to substitute for HRV-14 oriI was not caused by the observed sequence differences. These studies employed a HRV-14 subgenomic replicon whose replication could be monitored by measuring luciferase activity ( Fig. 2B ) (32). In this system, HRV-14 oriI yielded an increase in luciferase activity 50-to 100-fold higher than a replicon lacking oriI ( Fig. 2C) (32). Addition of PV-1 oriI to the HRV-14 replicon containing the oriI deletion did not restore replication to the level expected for HRV-14 oriI (Fig. 2C) . Importantly, adaptive mutations in 3C (L94P) and 3D (D406N) isolated by using PV-3 oriI also increased utilization of PV-1 oriI (Fig. 2C) . As observed previously (32), the two adaptive mutations were at least additive, possibly synergistic (Fig. 2C) , suggesting independent mechanisms for the adaptive mutations.
PV-1 oriI does not substitute for HRV-14 oriI in vitro. VPg uridylylation has been reconstituted in vitro from purified components for a variety of picornaviruses (7, 25) , but a system to study HRV-14 VPg uridylylation has not been developed. Reconstitution of HRV-14
VPg uridylylation in vitro would facilitate determination of how the adaptive changes in 3C-and We have expressed and purified HRV-14 3C, 3Dpol and 3CD (Fig. 3A) by using the pET-ubiquitin system and purification schemes described previously for the analogous PV-1 proteins (8) . Production of VPg-pU(pU) was observed in a reconstituted in vitro VPg uridylylation reaction containing HRV-14 3Dpol, 3C(D), VPg and HRV-14 oriI (Fig. 3B) . This reaction was linear for at least two hours (Fig. 3C) . We were unable to chase the VPg-pU product formed into VPg-pUpU product over time (data not shown), suggesting that once VPgpU dissociates, rebinding of this product in a productive conformation may not occur.
Importantly, PV-1 oriI was not an efficient template for VPg uridylylation catalyzed by using HRV-14 replication proteins ( Fig. 3C) , consistent with observations made in tissue culture ( Fig. 4A ). These data are consistent with the adaptive mutation in 3D-coding sequence functioning at the level of 3Dpol, not 3CD. Importantly, the increased activity of the 3Dpol-D406N derivative was not restricted to the heterologous PV-1 oriI, but was observed with the related HRV-14 RNA element as well. This observation suggests that its increased activity is not dependent upon specific sequence or structure differences in oriI; however, the increased VPg uridylylation activity of this derivative was not merely due to a change in polymerase activity as both enzymes exhibited equivalent poly(rU) polymerase activity (data not shown). and suggests that the two mutations function by independent mechanisms. We conclude that the in vitro HRV-14 VPg uridylylation system recapitulates biological phenotypes and thus can be used to define biologically relevant mechanisms. 3Dpol did not assemble readily on the synthetic primed-template substrate (sym/sub) designed for mechanistic studies of PV-1 3Dpol (data not shown) (2) . In order to prove that the D406N change did not function by changing a more general activity of 3Dpol, we engineered this substitution into PV-1 3Dpol. PV-1 3Dpol-D406N was 4 fold more efficient than wt 3Dpol at VPg uridylylation ( Table 2 ). Significant differences were not observed in the poly(rU) polymerase activity, pre-steady-state constant for single nucleotide (AMP) incorporation or steady-state rate constant for AMP incorporation ( Table 2) . We conclude that the gain-offunction associated with the D406N substitution is unique to the VPg uridylylation reaction and is not caused by some indirect effect on polymerase activity.
3Dpol-D406N is recruited to and retained in VPg uridylylation complexes more efficiently than wt 3Dpol. In order to determine the mechanistic basis for the increased VPg uridylylation activity of 3Dpol-D406N relative to wt 3Dpol, we titrated each of the HRV components in reactions as follows: HRV-14 oriI (Fig. 5A) , HRV-14 3C (Fig. 5B) and HRV-14 VPg (Fig. 5C) .
The data were evaluated in two ways. First, the amount of VPg extended was plotted as a function of the concentration of the indicated reaction component, and the data were fit to a In all cases, 3Dpol-D406N extended more VPg molecules than wt 3Dpol (panel i of Figs.
5A
, 5B and 5C). We interpret this to mean that 3Dpol-D406N was recruited more efficiently to the VPg uridylylation complex. The K 0.5 value of 3Dpol-D406N for HRV-14 oriI was reduced 8
fold relative to wt (panel i of Fig. 5A ). Because the active form of oriI is a 3C 2 -oriI complex complex if the kinetics of 3C 2 -oriI assembly is faster than dissociation of VPg-pU from 3Dpol.
Interestingly, at saturating concentrations of HRV-14 VPg, the processivity of 3Dpol-D406N
(0.41 +/-0.03) was greater than wt 3Dpol (0.33 +/-0.03), suggesting that 3Dpol-D406N was retained in the VPg uridylylation complex more efficiently than wt 3Dpol (panel ii of Fig. 5C ).
3C-L94P assembles with oriI more efficiently and more stably than wt 3C. The adaptive change in 3C was evaluated as described above for 3Dpol (Fig. 6) . Evidence for a two-step mechanism for oriI binding to 3C. The data presented thus far are consistent with the 3C adaptive mutation increasing the affinity of this derivative for PV-1 oriI relative to wt 3C. This possibility was tested by using an RNA filter-binding assay (Fig. 7) .
Previous studies predict the two-step binding mechanism for oriI binding to 3C shown in Fig. 7A (21). OriI binds to two molecules of 3C, facilitating formation of a 3C dimer (3C 2 ), producing a ground-state complex (3C 2 -oriI) that isomerizes into an activated complex (3C 2 -oriI*) competent for recruitment of polymerase and uridylylation. We assumed that the 3C 2 -oriI complex would be in rapid equilibrium relative to formation of the 3C 2 -oriI* complex and that formation of the 17 We performed a direct binding experiment in which labeled HRV-14 oriI or PV-1 oriI was mixed with different concentrations of 3C for a short period of time (~15 s) to limit the amount of isomerization that could occur followed by filter-binding and filter-washing steps.
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The result of this experiment is shown in Fig. 7B . The K 0.5 value for HRV-14 oriI binding to wt 3C was 30 ±10 nM; the K 0.5 value for PV-1 oriI binding to wt 3C was 80 ± 40 nM. These two values are identical within the error of the measurement.
If an isomerized complex exists, then by incubating the binding mixture for longer periods of time, lower K 0.5 values should be observed in a direct-binding mode. The problem is that in order to obtain a K 0.5 value the concentration of labeled RNA employed must be on the order of 10-fold lower than the K 0.5 value, causing a substantial reduction in the signal:noise ratio.
In order to circumvent this problem, we used a competitive-binding mode.
WT 3C was mixed with labeled HRV-14 oriI in the absence or presence of different concentrations of unlabeled, competitor (either HRV-14 or PV-1). The binding reaction was incubated for 15 min to permit the reaction to reach equilibrium followed by filter binding and filter washing. If an isomerization step exists that contributes to the specificity of 3C binding, then unlabeled PV-1 oriI should not compete away labeled HRV-14 oriI as well as unlabeled HRV-14 oriI. As shown in Fig. 7C , at equilibrium HRV-14 oriI binds to wt 3C 25-fold better than PV-1 oriI. Together, these data provide additional support for the existence an isomerization step after oriI binding to 3C that imparts specificity to 3C binding.
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on July 8, 2017 by guest http://jvi.asm.org/ Downloaded from PV-1 oriI binds to 3C-L94P better than to wt 3C. In order to determine whether 3C-L94P exhibited a change in affinity/specificity for PV-1 oriI, we performed a competition-binding experiment as described above. The affinity of 3C-L94P for PV-1 oriI increased by 3 fold relative to wt 3C (Fig. 7D) , providing an explanation for the ability of 3C-L94P to support more robust VPg uridylylation by using PV-1 oriI. A 2 fold increase in the affinity for HRV-14 oriI was also noted (Fig. 7D) . Given the high ground-state affinity of wt 3C for HRV-14 oriI, it is possible that the magnitude of the effect of the adaptive mutation on HRV-14 oriI binding could be greater but is at the limit of resolution for the experimental design. (Fig 7B) . We thus conclude that differences in oriI secondary structure (Fig 2A) do not contribute significantly to the observed difference in oriI recognition by 3C. By using a series of HRV-14-PV-1 oriI chimeras (Fig. 8A) , we showed that the upper stem of HRV-14 oriI was more important than the loop in supporting formation of a stable 3C 2 -oriI complex (Fig. 8B) , suggesting a sequencespecific interaction between 3C and oriI after unwinding. The preferences observed here were also observed in the context of HRV-14 replicon RNAs containing these chimeric RNAs (32). Although the factor and element requirements for VPg uridylylation are well established, the mechanism for assembly and stability, stoichiometry and organization of the VPg uridylylation complex have only recently begun to be defined ( Fig. 1) 
Figs 7C and 7D
). This higher affinity was due to the upper stem as a PV-3/HRV-14 oriI chimera containing the HRV-14 stem bound to 3C better than a chimera containing the HRV-14 loop (Fig. 8) . We conclude that 3C binds to the upper stem of oriI in a sequence-independent fashion that may be structure sensitive. This complex isomerizes into a form that is stabilized by sequence-specific interactions with upper stem of oriI. A sequence-specific interaction between 3C and the stem would likely require opening after 3C binding, consistent with a two-step binding mechanism (21) . Although the bases of double-stranded DNA are accessible from the major groove (20) , the bases of double-stranded RNA are much less accessible to protein (5).
We propose that HRV-14 3C exhibits greater sequence specificity than PV 3C. The more 21 (Fig. 2C) .
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HRV-14 3C-L94P still exhibited a preference for binding HRV-14 oriI (Fig. 8) . Leu-94 is not conserved across all picornavirus 3C proteins; however, this region of 3C protein has been shown previously to be involved in RNA binding (19 (19) . We have also identified this region as a determinant for PV-1 oriI binding by PV-1 3C by using NMR spectroscopy (unpublished observations). We conclude that after formation of the initial 3C 2 -oriI complex, the duplex opens and each 3C molecule interacts with single-stranded RNA in a sequence-dependent fashion by using residues in the vicinity of residue 94. The adaptive change in 3C not only increases the affinity of this 3C derivative for RNA in general but also expands the sequence specificity of the protein resulting in the formation of more stable VPg uridylylation complexes.
This two-step, sequence-specific binding mechanism observed for 3C binding to oriI may also be required for 3C binding to cis-acting replication elements at the 5'-and 3'-end of picornaviral genomes. Table 2) . 3Dpol-D406N was not more active than wt 3Dpol as RNA-primed elongation activity was unchanged (data not shown and Table 2 ). HRV-14 3Dpol-D406N assembled more readily into the HRV-14 3C 2 -oriI complex as the K 0.5 value for oriI was reduced by 8 fold relative to wt 3Dpol to 2 M (panel i of for assembly of the VPg uridylylation complex ( Fig. 1 and (21)), we conclude that 3Dpol-D406N assembles more efficiently and more stably with the 3C dimer leading to increased production of more processive VPg uridylylation complexes.
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Assembly of stable VPg uridylylation complexes is essential for picornavirus genome replication. This study suggests that the kinetics of assembly and overall stability of the HRV-14
VPg uridylylation complex exist at the optimal value, leading to a rate of VPg uridylylation that prevents this step in viral RNA synthesis from being rate limiting in infected cells. Substitution of PV oriI into the HRV-14 genome reduces replication, most likely due to a reduced level of VPg-pUpU production (Fig. 3) . kinetics of assembly and/or overall stability of the PV-1 VPg uridylylation complex greatly exceed the optimal value. If this is the case, then PV-1 may be more tolerant to changes or disruptions in VPg uridylylation components. For example, it has been suggested that oriItemplated production of VPg-pUpU is not required for PV-1 negative-strand RNA synthesis based on the observation that mutations in PV-1 oriI that severely impair VPg uridylylation have no impact on negative-strand RNA synthesis in a cell-free system (17, 18). If PV-1 produces far more VPg-pUpU than needed, then even a substantial reduction in the concentration of VPgpUpU may be tolerated. Therefore, it remains possible that oriI is used for negative-strand RNA synthesis (16) . Given the sensitivity of HRV-14 to changes in oriI, this system may be useful in clarifying this issue. Step 1: Two 3CD molecules bind to oriI with the 3C domains contacting the upper stem (solid lines) and the 3D domains contacting the lower stem (dashed lines).
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Step 2: The 3C dimer opens the RNA stem by forming a more stable interaction with single strands forming the stem.
Step 3:
3Dpol is recruited to and retained in this complex by a physical interaction between the back of the thumb sub-domain of 3Dpol and a surface of one or both 3C sub-domains of 3CD. uridylylation reactions were performed as described above to determine the effect of combining 3C* and 3D* on PV-1 utilization. The assumption here is that if the molecular mechanism for adaptation of both proteins is the same, then the combination would be less than additive or even antagonistic. However, independent mechanisms should lead to an additive or synergistic increase in product formation. The combination was at least additive, possibly synergistic. 
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